A Study of LNK01001 Capsule in Patients With Ankylosing Spondylitis
Status:
Completed
Trial end date:
2023-06-20
Target enrollment:
Participant gender:
Summary
The objective of this study was to evaluate the safety and efficacy of multiple doses of
LNK01001 monotherapy versus placebo in the treatment of adults with active Ankylosing
Spondylitis